key: cord-0744126-2un48l2e
authors: nan
title: Acknowledgement to Referees
date: 2021-11-15
journal: Drugs Real World Outcomes
DOI: 10.1007/s40801-021-00285-0
sha: 39bdc8251780c85394157a4e3bf0a5688bac1518
doc_id: 744126
cord_uid: 2un48l2e

nan

Social media sharing and other online mentions of information are other metrics with which to measure the reach of articles. This year, the following articles published in Drugs-Real World Outcomes scored highly on the Altmetric system: Fung KW, Baye F, Kapusnik-Uner J, et al. Using Medicare data to assess the proarrhythmic risk of non-cardiac treatment drugs that prolong the QT interval in older adults: an observational cohort study. https:// doi. org/ 10. 1007/ s40801-021-00230-1 Mehdizadeh D, Hale M, Todd O, et al. Associations between anticholinergic medication exposure and adverse health outcomes in older people with frailty: a systematic review and meta-analysis. https:// doi. org/ 10. 1007/ s40801-021-00256-5 Vickers LE, Martinez AI, Wallem AM, et al. Potentially inappropriate medication use in older adults with Alzheimer's disease and related dementias living in the community: a cross-sectional analysis. https:// doi. org/ 10. 1007/ s40801-021-00265-4 Cuppens K, Lodewyckx L, Demedts I, et al. Real-world treatment patterns, epidermal growth factor receptor (EGFR) testing and outcomes in EGFR-mutated advanced non-small cell lung cancer patients in Belgium: results from the REVEAL study. https:// doi. org/ 10. 1007/ s40801-021-00243-w

The COVID-19 pandemic has continued to present many challenges, and we would like to thank all who have contributed to ensuring the journal has thrived despite the ongoing issues.

We would like to start by thanking the authors of the articles published in Drugs-Real World Outcomes over the course of 2021. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success.

The quality of published articles is also testament to the diligence of the peer reviewers. We would like to acknowledge the following individuals who acted as reviewers for Drugs-Real World Outcomes in the last 12 months:

terms of important company initiatives, Springer Nature has continued to support the global response to COVID-19 by making all relevant content immediately and freely available. The Springer Nature Sustainable Development Goals (SDG) Programme is aiming to connect researchers who are tackling the world's toughest challenges with practitioners in policy and business. The Women in Science initiative aims to help empower more women scientists to achieve scientific excellence. Finally, we are delighted to inform you that Springer Nature is now carbon neutral for its direct operations (offices, fleet, and flights

which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder

We are also very grateful to the members of the journal's Honorary Editorial Board, who have acted as peer reviewers and authors and provided guidance on journal content, policy, and processes: G. C. Alexander, Johns Hopkins University, Baltimore, MD, USA